Specific mutation screening of TP53 gene by low-density DNA microarray

被引:0
|
作者
Rangel-Lopez, Angelica [1 ,2 ,3 ]
Mendez-Tenorio, Alfonso [3 ]
Beattie, Kenneth L. [4 ]
Maldonado, Rogelio [3 ]
Mendoza, Patricia [1 ]
Vazquez, Guelaguetza [1 ]
Perez-Plasencia, Carlos [5 ]
Sanchez, Martha [2 ]
Navarro, Guillermo [6 ]
Salcedo, Mauricio [1 ]
机构
[1] Hosp Oncol, Lab Oncol Genom, Unidad Invest Med Enfermedades Oncol, CMN Siglo XXI IMSS, Mexico City, DF, Mexico
[2] Hosp Especialidades Ctr Med La Raza, CMN Siglo XXI IMSS, Unidad Invest Med Enfermedades Nefrol, Mexico City, DF, Mexico
[3] Escuela Nacl Ciencias Biol, Lab Biotecnol & Bioinformat Genom, Ipn Mexico City, Mexico
[4] Amerigenics Inc, Crossville, TN USA
[5] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City, DF, Mexico
[6] Univ Nacl Autonoma Mexico, Lab Organomet, Mexico City, DF, Mexico
关键词
oligonucleotide microarray; TP53; gene; point mutations;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
TP53 is the most commonly mutated gene in human cancers. Approximately 90% of mutations in this gene are localized between domains encoding exons 5 to 8. The aim of this investigation was to examine the ability of the low density DNA microarray with the assistance of double tandem hybridization platform to characterize TP53 mutational hotspots in exons 5, 7, and 8 of the TP53. Nineteen capture probes specific to each potential mutation site were designed to hybridize to specific site. Virtual hybridization was used to predict the stability of hybridization of each capture probe with the target. Thirty-three DNA samples from different sources were analyzed for mutants in these exons. A total of 32 codon substitutions were found by DNA sequencing. 24 of them a showed a perfect correlation with the hybridization pattern system and DNA sequencing analysis of the regions scanned. Although in this work we directed our attention to some of the most representative mutations of the TP53 gene, the results suggest that this microarray system proved to be a rapid, reliable, and effective method for screening all the mutations in TP53 gene.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [41] Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
    Saba, Karim H.
    Difilippo, Valeria
    Kovac, Michal
    Cornmark, Louise
    Magnusson, Linda
    Nilsson, Jenny
    van den Bos, Hilda
    Spierings, Diana C. J.
    Bidgoli, Mahtab
    Jonson, Tord
    Sumathi, Vaiyapuri P.
    Brosjoe, Otte
    Staaf, Johan
    Foijer, Floris
    Styring, Emelie
    Nathrath, Michaela
    Baumhoer, Daniel
    Nord, Karolin H.
    JOURNAL OF PATHOLOGY, 2024, 262 (02): : 147 - 160
  • [42] Clinical significance of TP53 mutation in myeloma
    Chng, W. J.
    Price-Troska, T.
    Gonzalez-Paz, N.
    Van Wier, S.
    Jacobus, S.
    Blood, E.
    Henderson, K.
    Oken, M.
    Van Ness, B.
    Greipp, P.
    Rajkumar, S. V.
    Fonseca, R.
    LEUKEMIA, 2007, 21 (03) : 582 - 584
  • [43] TP53 mutation in mucinous carcinoma of the breast
    Di Palma, S
    Lavarino, C
    Oggionni, M
    Pilotti, S
    HISTOPATHOLOGY, 1999, 34 (06) : 559 - 560
  • [44] Sarcomas in TP53 germline mutation carriers
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER RESEARCH, 2011, 71
  • [45] TP53 mutation is rare in primary myelofibrosis
    Greaves, Wesley O.
    Verma, Shalini
    Bisrat, Tigist
    Strati, Paolo
    Rahimi, Hamed
    Paladugu, Abhaya V.
    Luthra, Rajyalakshmi
    Patel, Keyur P.
    Medeiros, L. Jeff Rey
    Yao, Hui
    Pierce, Sherry
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1552 - 1552
  • [46] Clinical significance of TP53 mutation in myeloma
    W J Chng
    T Price-Troska
    N Gonzalez-Paz
    S Van Wier
    S Jacobus
    E Blood
    K Henderson
    M Oken
    B Van Ness
    P Greipp
    S V Rajkumar
    R Fonseca
    Leukemia, 2007, 21 : 582 - 584
  • [47] Is the TP53 gene the elephant in the room?
    Sodhi, Nidhi
    AUSTRALIAN VETERINARY JOURNAL, 2016, 94 (06) : N10 - N10
  • [48] The role of TP53 mutation status in the response to DNA methyltransferase inhibitor treatment
    Omar, Khadra K.
    Grundy, Erin E.
    Cox, Olivia
    Hadley, Melissa
    Chiappinelli, Katherine B.
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [50] Analysis of mutation and promoter methylation of TP53 gene in tumors of the head and neck
    Jarzynski, Adrian
    Papiernik, Katarzyna
    Polz-Dacewicz, Malgorzata
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2016, 29 (02) : 53 - 56